95-033 | Â | Â | Â | Â | Â |
---|---|---|---|---|---|
Case # | Age | Gender | Tumor | # of previous recurrence | Vaccine/Adverse events |
1 | 63 | Male | Lt. Temporal GBM | 2 | Yes/Grade 2 skin reaction |
2 | 60 | Male | Lt. Temporal AA | 3 | Yes/Grade 1 skin reaction |
3 | 40 | Male | Rt. Frontal GBM | 3 | No due to tumor progression |
4 | 57 | Male | Lt. Parieto/Occi GBM | 1 | No due to tumor progression |
5 | 32 | Female | Lt. Parieto/Occi GBM | 1 | No due to tumor progression |
6 | 53 | Female | Rt. Frontal GBM | 2 | No due to tumor progression |
99-111 | Â | Â | Â | Â | Â |
Case # | Age | Gender | Tumor | TTP (Months) | Vaccine/Adverse events |
1 | 56 | Male | Lt. Parietal GBM | 4 | Yes/Grade 1 headache |
2 | 66 | Male | Rt. Frontal GBM | N/A | No due to tumor progression |
3 | 45 | Male | Lt. Temporal GBM | 10 | Yes/None |
4 | 53 | Male | Lt. Occipital GBM | 6 | Yes/None |
5 | 50 | Male | Rt. Frontal GBM | 6 | Yes/None |
6 | 61 | Female | Rt. Temporal GBM | 4 | Yes/None |